Quest Diagnostics EVP executes $263k in stock disposals around tax vesting and 10b5-1 plan
Catherine T. Doherty, Executive Vice President at Quest Diagnostics (DGX), completed two separate stock disposals on March 2 and March 3, 2026. One sale on March 3 involved 632 shares at $207.73 worth $131,285. A March 2 disposal of 648 shares at $204.86, totaling $132,749, was executed to cover tax obligations tied to vesting restricted share unit…